Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Different countries have regulations to ensure the safety of hair care products, with some recalling hair straighteners due to high formaldehyde.

The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

PRP treatments for hair loss need standard protocols to be reliable.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Most people using biotin don't see skin improvements, and it may affect lab tests, so doctors shouldn't suggest it without confirming a deficiency.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

New treatments are needed for non-scarring alopecia due to current limitations.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.